# Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs

> **NCT03077711** · PHASE4 · COMPLETED · sponsor: **Endeavor Health** · enrollment: 92 (actual)

## Conditions studied

- Urinary Tract Infections, Recurrent

## Interventions

- **DRUG:** Trimethoprim
- **DRUG:** Methenamine hippurate

## Key facts

- **NCT ID:** NCT03077711
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2019-06-21
- **Final completion:** 2019-06-21
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03077711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03077711, "Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03077711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
